Who makes Dofetilide and Diltiazem?

Dofetilide and Diltiazem is developed by Food and Drug Administration (FDA).

What development phase is Dofetilide and Diltiazem in?

Dofetilide and Diltiazem is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Dofetilide and Diltiazem

Food and Drug Administration (FDA) · Phase 1 active Small molecule

At a glance

Generic name	Dofetilide and Diltiazem
Sponsor	Food and Drug Administration (FDA)
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dofetilide and Diltiazem CI brief — competitive landscape report
Dofetilide and Diltiazem updates RSS · CI watch RSS
Food and Drug Administration (FDA) portfolio CI